Why PFO Closure is an Exciting Therapy
Megan Coylewright, MD MPH Interventional Cardiology Associate Director, Structural Heart Disease Program Dartmouth-Hitchcock Medical Center
Why PFO Closure is an Exciting Therapy Megan Coylewright, MD MPH - - PowerPoint PPT Presentation
Why PFO Closure is an Exciting Therapy Megan Coylewright, MD MPH Interventional Cardiology Associate Director, Structural Heart Disease Program Dartmouth-Hitchcock Medical Center Disclosures Edwards LifeSciences Boston Scientific
Megan Coylewright, MD MPH Interventional Cardiology Associate Director, Structural Heart Disease Program Dartmouth-Hitchcock Medical Center
REDUCE Study Data1 RESPECT Study Data2 Device – or procedure-related SAE 3.6% 4.2% Device-related SAE 1.4% 2.6% Procedure-related SAE 2.5% 2.4%
Total Length of procedure Back to Strenuous Activities 1-2 hours 2 weeks
Physician Reimbursement
communication (ie, Fontan fenestration, atrial septal defect) with implant - $1025.31
Hospital Outpatient
Hospital Inpatient
https://www.bmj.com/conten t/362/bmj.k2515/infographic